Compare Ishares Msci Brazil ETF (EWZ) vs Moderna, Inc. (MRNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ishares Msci Brazil ETF vs Moderna, Inc. — how do they compare? Ishares Msci Brazil ETF trades at $35.36, while Moderna, Inc. trades at $64.33 (market cap $27.09B). The key difference: Moderna, Inc. is trading nearer its 52-week high, Ishares Msci Brazil ETF nearer its low. Which is the better fit depends on your goals.
| EWZ | MRNA | |
|---|---|---|
Sector | Broad Market / Factor | Health |
52-Week High | $41.75 | $81.80 |
52-Week Low | $26.52 | $22.36 |
Market Cap | — | $27.09B |
Enterprise Value | — | $23.19B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EWZ, the iShares MSCI Brazil ETF, trades at $35.33, down 1.94% on the day, yet maintains a bullish technical signal with strong moving average support. The ETF has gained approximately 11% year-to-date, driven by Brazil's monetary easing cycle and commodity strength. Recent news highlights Brazil's economic initiatives and the ETF's exposure to Latin America's equity rally, though key financial ratios like P/E and P/B are not provided in the snapshot.
The outlook for EWZ is cautiously optimistic, with potential upside from Brazil's rate cuts and commodity tailwinds, but risks include economic volatility and reliance on key holdings like Petrobras and Vale. Investors should weigh the concentrated exposure and external factors affecting emerging markets.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ishares Msci Brazil ETF
EWZ is a country-specific ETF that tracks the Brazilian equity market. It provides exposure to large and mid-sized companies in Brazil, with a heavy focus on financials and materials, including major names like Nu Holdings, Vale, and Itaú Unibanco.
Read more on EWZ →About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →
